Back to Search
Start Over
Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.
- Source :
-
Frontiers in pharmacology [Front Pharmacol] 2024 Jun 27; Vol. 15, pp. 1428755. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Details
- Language :
- English
- ISSN :
- 1663-9812
- Volume :
- 15
- Database :
- MEDLINE
- Journal :
- Frontiers in pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 38994207
- Full Text :
- https://doi.org/10.3389/fphar.2024.1428755